[37B11-37B11];[37D3-37D3];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
37B11;37D3
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Df(2L)BSC341 homozygous embryos do not show any obvious musculature phenotype.
The presence of P+PBac{XP5.RB3}BSC341 was verified using the PCR methods and primers described in FBrf0175003 with the substitution of the primer 5'-CCAATGCGTTTATTTCAGGTCACG-3' for the RB3' plus or RB3' minus primer in the Hybrid PCR protocol in the Supplementary Methods.
The cytological breakpoints of Df(2L)BSC341 predicted from the Release 5 genomic coordinates of the P{XP}Catsupd07915 and PBac{RB}CG17350e03687 transposable element insertions sites are 37B11;37D3.